C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/1992
12/10/1992	WO1992021781A1 Tumor suppressor
12/10/1992	WO1992021771A1 Epidermal growth factor receptor ectodomain
12/10/1992	WO1992021767A1 Me20: monoclonal antibodies and antigen for human melanoma
12/10/1992	WO1992021766A1 Monoclonal antibodies against c-kit
12/10/1992	WO1992021761A1 Method and materials for introducing dna into prevotella ruminicola
12/10/1992	WO1992021758A1 Mycobacterium proteins and applications
12/10/1992	WO1992021757A1 Nematode-responsive plant promoters
12/10/1992	WO1992021756A1 Methods and compositions relating to genetically engineered cells that produce insulin in response to glucose
12/10/1992	WO1992021754A1 Dna which codes for secretin receptor and polypeptide which is coded for by said dna
12/10/1992	WO1992021753A1 Insecticidal proteins and method for plant protection
12/10/1992	WO1992021752A1 Human lactoferrin
12/10/1992	WO1992021751A1 Bovine herpesvirus type 1 deletion mutants, vaccines based thereon, diagnostic kits for detection of bovine herpesvirus type 1
12/10/1992	WO1992021747A1 Methods and compositions of genetic stress response systems
12/10/1992	WO1992021746A1 Device and method for the analysis of rolling blood leukocytes and identifying inhibitors and promoters
12/10/1992	WO1992021702A1 Specifically beta-beta cross-linked hemoglobins and method of preparation
12/10/1992	WO1992021701A1 Transfected mammalian cell lines expressing the a1 adenosine receptor
12/10/1992	WO1992021699A1 Biocidal proteins
12/10/1992	WO1992021698A1 DETECTION OF COLLAGEN DEGRADATION $i(IN VIVO)
12/10/1992	WO1992021697A2 Diagnostic peptides derived from m.tuberculosis antigens
12/10/1992	WO1992021696A1 Hydroxyazido derivatives and related compounds as renin inhibitors
12/10/1992	WO1992021694A1 Molecular diagnosis of autosomal dominant charcot-marie-tooth disease
12/10/1992	WO1992021380A1 Method to treat kaposi's sarcoma
12/10/1992	WO1992021377A1 Peptides for use in induction of t cell activation against hiv-1
12/10/1992	WO1992021376A1 Induction of ctl responses to foreign antigens expressed in mycobacteria
12/10/1992	WO1992021374A1 Induction of immune response against tetanus toxin through administration of mycobacteria expressing tetanus toxin or fragments
12/10/1992	WO1992021370A1 Fish vaccine for aeromonas salmonicida infection
12/10/1992	WO1992021367A1 T cell receptor peptides as therapeutics for immune-related disease
12/10/1992	WO1992021364A1 Cea-binding proteins and methods for their isolation and use
12/10/1992	WO1992021361A1 Terminally modified tri-, tetra- and pentapeptide anaphylatoxin receptor ligands
12/10/1992	WO1992021360A1 Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative active agents
12/10/1992	WO1992021247A1 Stabilisation of plant extracts
12/10/1992	WO1992021240A1 Suppressor t-cell hybridoma
12/10/1992	WO1992017493A3 Peptides and mixtures thereof for detecting antibodies to hepatitis c virus (hcv)
12/10/1992	WO1992017025A3 GnRH analogs
12/10/1992	WO1992014821A3 Nestin expression as an indicator of neuroepithelial tumors
12/10/1992	WO1992014818A3 Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences
12/10/1992	WO1992013878A3 Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same
12/10/1992	WO1992013078A3 Pasteurella haemolytica glycoprotease gene and the purified enzyme
12/10/1992	WO1992012996A3 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations
12/10/1992	WO1992009690A3 Enrichment method for variant proteins with altered binding properties
12/10/1992	DE4118770A1 Preparing antibodies against unstable antigens, esp. active anaphylatoxin - by direct contact of immunogen and spleen cells, useful diagnostically and for treating elevated complement activation
12/10/1992	DE4118155A1 Acid-stable mutants of human rhinovirus serotype 14 - used for treatment of rhino-viral infection obtd. by incubating wild type virus at varying pH cycles
12/10/1992	CA2110924A1 Method and materials for introducing dna into prevotella ruminicola
12/10/1992	CA2110690A1 Fish vaccine for aeromonas salmonicida infection
12/10/1992	CA2110687A1 Induction of immune response against tetanus toxin through administration of mycobacteria expressing tetanus toxin or fragments
12/10/1992	CA2110682A1 Induction of ctl responses to foreign antigens expressed in mycobacteria
12/10/1992	CA2110404A1 Human lactoferrin
12/10/1992	CA2110403A1 Biocidal proteins
12/10/1992	CA2110389A1 Mycobacterium proteins and applications
12/10/1992	CA2110381A1 Hydroxyazido derivatives and related compounds as renin inhibitors
12/10/1992	CA2110292A1 Device and method for the analysis of rolling blood leukocytes and identifying inhibitors and promoters
12/10/1992	CA2110263A1 Detection of collagen degradation in vivo
12/10/1992	CA2110169A1 Nematode-responsive plant promoters
12/10/1992	CA2110038A1 Stabilisation of plant extracts
12/10/1992	CA2109822A1 Diagnostic peptides derived from m.tuberculosis antigens
12/10/1992	CA2109819A1 Insecticidal proteins and method for plant protection
12/10/1992	CA2103365A1 Methods and compositions relating to genetically engineered cells that produce insulin in response to glucose
12/10/1992	CA2103046A1 Suppressor t-cell hybridoma
12/10/1992	CA2102890A1 Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative active agents
12/09/1992	EP0517464A1 Peptides useful in regulating the immune and nervous systems
12/09/1992	EP0517370A1 Quantitation of samples using capillary electrophoresis
12/09/1992	EP0517367A1 Novel nematode-active toxins and genes which code therefor
12/09/1992	EP0517292A1 Recombinant Avipox virus
12/09/1992	EP0517174A2 LFA-3 protein and derivatives
12/09/1992	EP0517024A2 Tetravalent bispecific receptors, their preparation and use
12/09/1992	EP0516859A1 Non-a non-b hepatitis virus antigen protein
12/09/1992	EP0516851A1 Physiologically active substance well capable of permeating biomembrane
12/09/1992	EP0516845A1 Novel megakaryocytic colony stimulating factor and process for its preparation
12/09/1992	EP0516787A1 Expression systems
12/09/1992	EP0516747A1 COMPOSITIONS AND METHODS FOR TREATING INFECTIONS CAUSED BY ORGANISMS SENSITIVE TO $g(b)-LACTAM ANTIBIOTICS
12/09/1992	EP0516721A1 Antigenic proteins of plasmodium
12/09/1992	EP0516718A1 A method and compositions to screen compounds for enhancement of the cholinergic, dopaminergic and serotonergic function
12/09/1992	EP0516704A1 Novel insulin compositions.
12/09/1992	EP0516655A1 Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine.
12/09/1992	EP0516647A1 Polypeptides involved in the biosynthesis of cobalamines and/or cobamides, dna sequences coding for these polypeptides, and their preparation and use
12/09/1992	CN1019355B Process for minactivin and its use
12/08/1992	US5169941 DNA sequences coding for the DR β-chain locus of the human lymphocyte antigen complex and polypeptides, diagnostic typing processes and products related thereto
12/08/1992	US5169940 Nucleotide sequences of protein MTP40 of M. tuberculosis
12/08/1992	US5169936 Protein purification on immobilized metal affinity resins effected by elution using a weak ligand
12/08/1992	US5169934 Intracellularly cleavable compounds
12/08/1992	US5169933 Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
12/08/1992	US5169932 Hormone inhibitors, antitumor agents
12/08/1992	US5169930 Integrin with preferential binding to fibronectin not vitronectin
12/08/1992	US5169841 Enzyme inhibitors, hypotensive agents, high enteral bioauailability
12/08/1992	US5169837 Isolated osteogenic factor
12/08/1992	US5169836 Inhibitors of platelet binding
12/08/1992	US5169835 Pregancy specific proteins applications
12/08/1992	US5169833 Analgesics
12/08/1992	US5169784 Baculovirus dual promoter expression vector
12/08/1992	US5169783 Mixing ice nuclei derived from algae fungus with water solution
12/08/1992	US5169766 Amplification of nucleic acid molecules
12/08/1992	US5169765 Method for stimulating production of bone marrow cell growth factors using dithiocarbamates
12/08/1992	US5169764 Multitrophic and multifunctional chimeric neurotrophic factors, and nucleic acids and plasmids encoding the chimeras
12/08/1992	US5169763 Contains promoter for expressing non-cleavable dna fragments with signal peptide in mammalian cells
12/08/1992	US5169762 Transforming Escherichia coli host cell with replicable expression vector which expresses isolated DNA sequence encoding human nerve growth factor polypeptide
12/08/1992	US5169761 Dna encoding and expression systems for alveolar surfactant proteins
12/08/1992	US5169753 Reacting human serum with fractionated proteins from retrovirus, then assaying for serum antibody binding to selected retroviral proteins
12/08/1992	US5169752 Methods and materials for HIV detection
12/08/1992	US5169629 Process of controlling lepidopteran pests, using bacillus thuringiensis isolate denoted b.t ps81gg
12/08/1992	US5169628 Vaccines

1 ... 2709 2710 2711 2712 2713 2714 2715 2716 2717 2718 2719 2720 2721 2722 2723 2724 2725 2726 2727 2728 2729 ... 2916